Papers
2
Total Citations
29
H-Index
2
About
Marco Abate is a leading urological oncology researcher whose work focuses on improving diagnosis and treatment strategies for prostate cancer, particularly in complex clinical scenarios. His research spans the intersection of advanced imaging, surgical pathology, and multidisciplinary cancer care. A standout contribution is his systematic review on managing prostate cancer in patients with previous or synchronous colorectal cancer—a challenging, understudied population—which has garnered 16 citations since 2022 and provides critical guidance for clinicians navigating dual malignancies. Abate also made significant strides in refining risk stratification, as demonstrated by his 2023 study on predicting cribriform variant status and perineural invasion in robot-assisted radical prostatectomy specimens. This work, with 13 citations, leverages the mpMRI era to identify preoperative predictors of adverse histopathological features, directly informing surgical planning and prognosis. By analyzing upgrading rates between biopsy and final pathology, Abate’s research enhances the precision of prostate cancer management. His contributions are vital for urologists and oncologists seeking evidence-based approaches to personalized treatment, establishing him as a key voice in contemporary prostate cancer research.
Research Focus
Key Achievements
Top Papers
- 1
- 2